CorMedix annual operating margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2024
2025
CorMedix's operating margin was 48.17% for fiscal 2025.
View full CorMedix company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 48.17% | +99.59 pp |
| 2024 | 2024-12-31 | −51.43% | +46768.49 pp |
| 2022 | 2022-12-31 | −46,819.91% | −31402.40 pp |
| 2021 | 2021-12-31 | −15,417.51% | −4039.08 pp |
| 2020 | 2020-12-31 | −11,378.44% | −3962.13 pp |
| 2019 | 2019-12-31 | −7,416.31% | −1165.87 pp |
| 2018 | 2018-12-31 | −6,250.44% | +3746.95 pp |
| 2017 | 2017-12-31 | −9,997.39% | +1051.41 pp |
| 2016 | 2016-12-31 | −11,048.80% | −3123.25 pp |
| 2015 | 2015-12-31 | −7,925.56% | −3222.26 pp |
| 2014 | 2014-12-31 | −4,703.30% | +240943.63 pp |
| 2013 | 2013-12-31 | −245,646.93% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 42.10% | −7.09 pp |
| Q1 2026 | 2026-03-31 | 49.96% | −1.54 pp |
| Q4 2025 | 2025-12-31 | 45.02% | +73.71 pp |
| Q3 2025 | 2025-09-30 | 50.56% | +1948.65 pp |
| Q2 2025 | 2025-06-30 | 49.18% | +28293.84 pp |
| Q1 2025 | 2025-03-31 | 51.49% | +102177.56 pp |
| Q3 2024 | 2024-09-30 | −28.70% | +38744.40 pp |
| Q2 2024 | 2024-06-30 | −1,898.09% | +90196.74 pp |
| Q4 2022 | 2022-12-31 | −28,244.66% | −14449.49 pp |
| Q3 2022 | 2022-09-30 | −102,126.07% | −79638.88 pp |
| Q2 2022 | 2022-06-30 | −38,773.09% | +33040.22 pp |
| Q1 2022 | 2022-03-31 | −92,094.83% | −83925.29 pp |
| Q4 2021 | 2021-12-31 | −13,795.16% | −2873.96 pp |
| Q3 2021 | 2021-09-30 | −22,487.18% | −15387.90 pp |
| Q2 2021 | 2021-06-30 | −71,813.31% | −17561.60 pp |
| Q1 2021 | 2021-03-31 | −8,169.54% | −591.63 pp |
| Q4 2020 | 2020-12-31 | −10,921.20% | +10774.75 pp |
| Q3 2020 | 2020-09-30 | −7,099.29% | +1587.96 pp |
| Q2 2020 | 2020-06-30 | −54,251.71% | −38550.03 pp |
| Q1 2020 | 2020-03-31 | −7,577.91% | −4570.33 pp |
| Q4 2019 | 2019-12-31 | −21,695.96% | −29758.06 pp |
| Q3 2019 | 2019-09-30 | −8,687.24% | −5937.96 pp |
| Q2 2019 | 2019-06-30 | −15,701.68% | +97821.69 pp |
| Q1 2019 | 2019-03-31 | −3,007.59% | +40890.83 pp |
| Q4 2018 | 2018-12-31 | 8,062.10% | +19162.38 pp |
| Q3 2018 | 2018-09-30 | −2,749.28% | +10368.97 pp |
| Q2 2018 | 2018-06-30 | −113,523.37% | −108366.07 pp |
| Q1 2018 | 2018-03-31 | −43,898.42% | −24638.57 pp |
| Q4 2017 | 2017-12-31 | −11,100.28% | −5725.32 pp |
| Q3 2017 | 2017-09-30 | −13,118.25% | +7484.16 pp |
| Q2 2017 | 2017-06-30 | −5,157.31% | +24593.89 pp |
| Q1 2017 | 2017-03-31 | −19,259.85% | −9245.76 pp |
| Q4 2016 | 2016-12-31 | −5,374.96% | +11591.61 pp |
| Q3 2016 | 2016-09-30 | −20,602.40% | −7492.66 pp |
| Q2 2016 | 2016-06-30 | −29,751.20% | −26304.93 pp |
| Q1 2016 | 2016-03-31 | −10,014.09% | +2504.05 pp |
| Q4 2015 | 2015-12-31 | −16,966.57% | −14358.46 pp |
| Q3 2015 | 2015-09-30 | −13,109.74% | −9556.16 pp |
| Q2 2015 | 2015-06-30 | −3,446.27% | +1310.26 pp |
| Q1 2015 | 2015-03-31 | −12,518.14% | +11529.63 pp |
| Q4 2014 | 2014-12-31 | −2,608.11% | +75573.15 pp |
| Q3 2014 | 2014-09-30 | −3,553.59% | — |
| Q2 2014 | 2014-06-30 | −4,756.53% | — |
| Q1 2014 | 2014-03-31 | −24,047.78% | — |
| Q4 2013 | 2013-12-31 | −78,181.26% | — |
Over the last five reported fiscal years, CorMedix's operating margin increased from −7,416.31% to 48.17%, a change of +7464.47 percentage points. The latest reported quarter, Q2 2026, shows 42.10%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CorMedix filings at SEC.gov ↗